Vanguard Group Inc

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-09
Total Holdings
16,744
Total Value
5531119721493
Accession Number
0001752724-25-099331
Form Type
13F-HR
Manager Name
Vanguard Group Inc
Data Enrichment
97% identified
16,290 identified454 unidentified

Holdings

16,744 positions
Manager:
Search and click to pin securities to the top
CHARLES & COLVARD LTD
Shares:
45367(+0.0%)
Value:
$43.6M(-27.8%)
STAR EQUITY HOLDINGS, INC.
Shares:
18655(-47.9%)
Value:
$42.2M(-47.9%)
AEye, Inc.
Shares:
73599(+0.0%)
Value:
$42.0M(-55.1%)
Forward Industries, Inc.
Shares:
10128(+0.0%)
Value:
$41.7M(-16.6%)
MARIN SOFTWARE INC
Shares:
30216(+0.0%)
Value:
$40.8M(-38.9%)
Power REIT
Shares:
36007(+0.0%)
Value:
$40.3M(-15.8%)
Arcadia Biosciences, Inc.
Shares:
14038(+0.0%)
Value:
$39.9M(-52.0%)
Hoth Therapeutics, Inc.
Shares:
38804(+0.0%)
Value:
$38.8M(+33.7%)
Edesa Biotech, Inc.
Shares:
15864(+0.0%)
Value:
$38.7M(+43.5%)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Shares:
17629(+0.0%)
Value:
$38.3M(-9.2%)
09075P204
Shares:
18824
Value:
$38.2M
Snail, Inc.
Shares:
43365(+267.9%)
Value:
$38.1M(+73.7%)
Hall of Fame Resort & Entertainment Co
Shares:
44745(-61.6%)
Value:
$37.2M(-75.5%)
New Concept Energy, Inc.
Shares:
48067(+0.0%)
Value:
$37.1M(-33.5%)
84862C302
Shares:
26319
Value:
$36.8M
RYVYL Inc.
Shares:
36087(+0.0%)
Value:
$35.7M(-23.8%)
BioSig Technologies, Inc.
Shares:
59263
Value:
$35.6M
BRAINSTORM CELL THERAPEUTICS INC.
Shares:
27724(-64.7%)
Value:
$34.9M(-80.4%)
AYTU BIOPHARMA, INC
Shares:
27888(+0.0%)
Value:
$33.5M(-28.1%)
BioCardia, Inc.
Shares:
12884(+0.0%)
Value:
$32.7M(+16.5%)